News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
La sede de Oryzon
ORYZON capta 30 millones de euros en una ampliación de capital internacional
Financing
Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP
Partners - Oryzon Genomics
Sede de ORYZON
ORYZON continues to strengthen its patent portfolio for vafidemstat
Healthcare · Innovative drugs
Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for…
Partners - Oryzon Genomics
Foto recurso cancer
ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadademstat plus immune checkpoint inhibitors in 1L extensive stage Small Cell Lung Cancer
Healthcare · Innovative drugs
Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the…
Partners - Oryzon Genomics
Maria_Jose_Aliaga_Gosalvez
#NewAseBioMember | “Being part of AseBio means joining a dynamic community committed to advancing biotechnology in Spain and beyond”
Corporate
Meet our new member Schrödinger. We sponke with María José Aliaga, Associate Account Manager.
AseBio - SCHRÖDINGER GMBH
Nota Convertible
Convertible Note vs. Capital Increase
Digitalization
The convertible note is a financing instrument that initially functions as a loan and is…
Partners - GENESIS Biomed
La Comisión Europea llama a la innovación frente al coronavirus
The European Commission proposes a new regulation to strengthen the supply and availability of Critical Medicines
Healthcare · Industrial biotechnology
The report highlights critical vulnerabilities within pharmaceutical supply chains in Europe and…
Miriam Corredor CEO de NoctuRNA
#NewAseBioMember | “AseBio is a key space for sharing experiences, generating synergies, and learning from start-ups”
Healthcare · Corporate
Meet our new member NoctuRNA. We spoke with a Miriam Corredor , CEO.  
AseBio - NOCTURNA THERAPEUTICS
La biotecnología en el desarrollo de ingredientes
Biotechnology in ingredient development
Healthcare · Agrifood
TECNALIA promotes projects such as INNOPROTEIN, which focus on developing new sources of proteins…
Partners - TECNALIA
NOTICIA BCN
BCN HEALTH publishes a study evaluating the costs due to productivity losses associated to cirrhosis in Spain
Healthcare · Access to innovation
Premature mortality from cirrhosis in Spain had an economic impact of over €2.4 billion in 2021,…
Partners - BCN Health